02/10/2026
This is what 17 days looked like for Talen.
The image on the right was taken on August 3rd. There was disease there, but compared to what came next, it was relatively small.
The image on the left was taken on August 19th.
Just 17 days later.
By then, Talen was incredibly unwell and fighting in PICU. In a little over two weeks, his Burkitt’s lymphoma had exploded through his body.
And this happened while he was still being actively treated.
He had chemotherapy.
He had CAR-T cells.
His doctors were doing everything they could.
And still, the cancer moved faster.
We were told Burkitt’s lymphoma was a highly curable childhood cancer. But when it relapses, and when it stops responding to treatment, that word curable can suddenly feel very different.
We watched our son’s cancer progress at an unimaginable speed despite active treatment.
This is why childhood cancer needs better protocols, better research and better funding.
We need more options for children whose cancer relapses.
More research into resistant and refractory Burkitt’s lymphoma.
More targeted treatments.
More answers when the standard options stop working.
Because 17 days should not be enough time for a child’s cancer to change this dramatically while they are still receiving treatment.
Talen deserved more options.
So does every child who comes after him.
Burkitt’s lymphoma needs more research. Childhood cancer needs more funding. Our kids deserve better. 🤍
My child shouldn't have had to be a sacrifice 💔